glp 1 agonists and inflammation Central glucagon-like peptide receptor activation inhibits Toll-like receptor agonist-induced inflammation: Cell Metabolism GLP-1 Receptor Agonists in Obese
Description
Japan was one of the first markets outside the U.S
Diabetes Res Clin Pract 174:108737 Ke Z, Ma Q, Ye X, Wang Y, Jin Y, Zhao X et al (2024) Peptide GLP-1 receptor agonists: from injection to oral delivery strategies
0.7% divided by 2.3% = 30% - is translated as a 30% relative difference when comparing one group to another
Pinheiro MM, de Souza LG, Nunes GP, et al
Over the long run, the oral version may also be less costly, Dr
